These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1450362)

  • 21. Ultrafiltration of dialysis fluid to obtain a sterile solution during hemodialysis.
    Bambauer R; Walther J; Jung WK
    Blood Purif; 1990; 8(6):309-17. PubMed ID: 2093329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the DialGuard device for endotoxin removal in hemodialysis.
    Szathmary S; Hegyi E; Amoureux MC; Rajapakse N; Chicorka L; Szalai G; Reszegi K; Derbyshire Z; Paluh J; Dodson B; Grandics P
    Blood Purif; 2004; 22(5):409-15. PubMed ID: 15316195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial and endotoxin contamination in water and dialysate in the central United States.
    Klein E; Pass T; Harding GB; Wright R; Million C
    Artif Organs; 1990 Apr; 14(2):85-94. PubMed ID: 2350260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis.
    Park S; Paredes W; Custodio M; Goel N; Sapkota D; Bandla A; Lynn RI; Reddy SM; Hostetter TH; Abramowitz MK
    Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1418-F1429. PubMed ID: 32308019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of anaphylactic shock induced by FX60 polysulfone hemodialyzer but not F6-HPS polysulfone hemodialyzer.
    Shu KH; Kao TW; Chiang WC; Wu VC
    Hemodial Int; 2014 Oct; 18(4):841-5. PubMed ID: 24923810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Membranes for endotoxin removal from dialysate: considerations on feasibility of commercial ceramic membranes.
    Bender H; Pfläzel A; Saunders N; Czermak P; Catapano G; Vienken J
    Artif Organs; 2000 Oct; 24(10):826-9. PubMed ID: 11091173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients.
    Yamagami S; Adachi T; Sugimura T; Kishimoto T; Maekawa M; Niwa M; Shaldon S
    ASAIO Trans; 1989; 35(3):331-3. PubMed ID: 2597475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrapure dialysate for home hemodialysis?
    Ouseph R; Ward RA
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):256-62. PubMed ID: 17603979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dialysate and biocompatibility in hemodialysis].
    Berland Y
    Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.
    Kiaii M; Djurdjev O; Farah M; Levin A; Jung B; MacRae J
    JAMA; 2011 Oct; 306(15):1679-87. PubMed ID: 22009100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis-associated adverse reactions with high-flux membranes and microbial contamination of liquid bicarbonate concentrate.
    Man NK; Ciancioni C; Faivre JM; Diab N; London G; Maret J; Wambergue FP
    Contrib Nephrol; 1988; 62():24-34. PubMed ID: 3359782
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiopulmonary events during hemodialysis: effects of dialysis membranes and dialysate buffers.
    Munger MA; Ateshkadi A; Cheung AK; Flaharty KK; Stoddard GJ; Marshall EH
    Am J Kidney Dis; 2000 Jul; 36(1):130-9. PubMed ID: 10873882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
    Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
    Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis modality, percentage of body fat, and patient survival.
    Stosovic M; Stanojevic M; Radovic M; Simic-Ogrizovic S; Lezaic V; Naumovic R; Jovanovic D; Ristic G; Djukanovic L; Marinkovic J
    Int J Artif Organs; 2009 Jan; 32(1):20-30. PubMed ID: 19241360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorine dioxide: a new agent for dialysis monitor disinfection in a pediatric center.
    Palo TD; Atti M; Bellantuono R; Giordano M; Caringella DA
    Blood Purif; 1997; 15(3):188-94. PubMed ID: 9262845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo studies of dialysis-related endotoxemia and bacteremia.
    Bernick JJ; Port FK; Favero MS
    Nephron; 1981; 27(6):307-12. PubMed ID: 7266719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyrogenic reactions associated with the reuse of disposable hollow-fiber hemodialyzers.
    Gordon SM; Tipple M; Bland LA; Jarvis WR
    JAMA; 1988 Oct; 260(14):2077-81. PubMed ID: 3418872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining the microbiological quality of dialysis fluid.
    Ledebo I; Nystrand R
    Artif Organs; 1999 Jan; 23(1):37-43. PubMed ID: 9950177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood.
    Linnenweber S; Lonnemann G
    ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.